|
European Postmarketing Surveillance Study of Sucrose-formulated
Recombinant Factor VIII for Severe Haemophilia A: Final Results
R. Musso,1 E. Santagostino,2 A. Faradji,3 M. Maas-Enriquez4
1Azienda Ospedale Vittorio Emanuele, Ospedale Ferrarotto, Catania, Italy; 2A. Bianchi Bonomi Haemophilia and Thrombosis Centre, IRCCS Maggiore Hospital;
3Haemophilia Regional Centre, Hospital de Hautepierre, Strasbourg, France; Bayer HealthCare, Leverkusen, Germany
原文下载：KogenateFS在欧洲上市后的监测研究
|
